Powered by

Powered by Portfolio Grader

Xenon Pharmace Cm Sh (XENE)

9.29 0.25 (2.62%) 16:00 EDT
XENE Stock Quote Delayed 15 Minutes
  • XENE Stock Chart

  • Historical XENE Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       -6.19
Market Cap:       163.62M
EPS:       -1.5
Volume:       31,894
Day's Range:       9.25 - 9.71
52wk Range:       5.27 - 15.92
Quotes delayed at least 20 mins.
Historical Data for XENE
Date Open High Low Volume Close Change %
04/01/19 10.32 10.35 9.66 108,219 10.10 -0.06   -0.59%
03/29/19 9.90 10.30 9.64 180,400 10.16 0.53   5.50%
03/28/19 9.43 9.63 9.30 36,112 9.63 0.21   2.23%
03/27/19 9.85 9.87 9.25 101,769 9.42 -0.37   -3.78%
03/26/19 9.54 10.00 9.33 73,844 9.79 0.26   2.73%
03/25/19 9.89 9.89 9.25 129,367 9.53 -0.28   -2.85%
03/22/19 10.42 10.48 9.63 184,300 9.81 -0.61   -5.85%
03/21/19 9.66 10.74 9.62 257,407 10.42 0.76   7.87%
03/20/19 9.60 9.87 9.33 65,453 9.66 0.06   0.63%
03/19/19 9.44 9.74 9.20 36,079 9.60 0.32   3.45%
03/18/19 9.49 9.78 9.25 64,490 9.28 -0.21   -2.21%
03/15/19 9.78 9.99 9.44 67,900 9.49 -0.34   -3.46%
03/14/19 9.28 10.00 9.28 194,064 9.83 0.56   6.04%
03/13/19 9.48 9.49 9.21 52,856 9.27 -0.20   -2.11%
03/12/19 9.23 9.56 9.14 86,895 9.47 0.25   2.71%
03/11/19 9.03 9.38 9.03 61,749 9.22 0.03   0.33%
03/08/19 9.29 9.45 9.01 86,200 9.19 -0.11   -1.18%
03/07/19 8.79 9.65 8.60 239,441 9.30 0.52   5.92%
03/06/19 8.69 8.89 8.60 167,274 8.78 0.11   1.27%
03/05/19 8.85 9.21 8.42 138,260 8.67 -0.17   -1.92%
03/04/19 8.95 8.96 8.38 117,481 8.84 -0.10   -1.12%
03/01/19 9.21 9.43 8.50 117,600 8.94 -0.24   -2.61%
02/28/19 9.05 9.20 8.40 212,233 9.18 0.06   0.66%
02/27/19 8.47 9.20 8.37 178,388 9.12 0.63   7.42%
02/26/19 8.22 8.50 8.01 127,814 8.49 0.32   3.92%
02/25/19 7.85 8.38 7.75 124,480 8.17 0.33   4.21%
02/22/19 7.79 7.84 7.58 28,300 7.84 0.12   1.55%
02/21/19 7.86 7.96 7.61 39,014 7.72 -0.18   -2.28%
02/20/19 8.02 8.32 7.83 125,019 7.90 -0.13   -1.62%
02/19/19 8.07 8.20 7.81 136,377 8.03 -0.05   -0.62%
02/15/19 8.03 8.12 7.77 75,100 8.08 0.06   0.75%
02/14/19 7.77 8.09 7.71 26,307 8.02 0.24   3.08%
02/13/19 7.89 8.05 7.73 40,901 7.78 -0.09   -1.14%
02/12/19 8.03 8.11 7.70 48,677 7.87 -0.09   -1.13%
02/11/19 8.24 8.24 7.67 52,358 7.96 -0.32   -3.86%
02/08/19 8.09 8.43 8.03 38,800 8.28 0.18   2.22%
02/07/19 8.43 8.43 7.82 87,960 8.10 -0.36   -4.26%
02/06/19 8.74 8.75 8.23 56,333 8.46 -0.29   -3.31%
02/05/19 8.62 8.80 8.62 66,548 8.75 0.15   1.74%
02/04/19 8.59 8.60 8.21 66,120 8.60 0.02   0.23%
02/01/19 8.56 8.59 8.13 60,500 8.58 0.04   0.47%
01/31/19 8.20 8.75 8.08 165,622 8.54 0.34   4.15%
01/30/19 8.05 8.20 7.91 63,396 8.20 0.15   1.86%
01/29/19 8.02 8.58 7.78 66,716 8.05 -0.02   -0.25%
01/28/19 8.00 8.30 7.98 60,190 8.07 0.15   1.89%
01/25/19 7.82 7.98 7.75 28,900 7.92 0.11   1.41%
01/24/19 7.75 7.84 7.68 19,234 7.81 0.09   1.17%
01/23/19 7.78 7.99 7.61 55,373 7.72 -0.03   -0.39%
01/22/19 7.65 7.90 7.55 100,811 7.75 0.10   1.31%
01/18/19 7.89 7.89 7.57 83,600 7.65 -0.16   -2.05%
01/17/19 7.66 7.86 7.66 45,067 7.81 0.11   1.43%
01/16/19 7.72 7.79 7.67 79,653 7.70 -0.01   -0.13%
01/15/19 7.63 7.95 7.59 46,861 7.71 0.12   1.58%
01/14/19 7.86 7.95 7.54 64,099 7.59 -0.37   -4.65%
01/11/19 7.85 8.02 7.71 70,600 7.96 0.18   2.31%
01/10/19 7.81 7.92 7.58 84,908 7.78 -0.11   -1.39%
01/09/19 8.21 8.34 7.77 144,288 7.89 -0.39   -4.71%
01/08/19 7.63 8.64 7.63 322,713 8.28 0.75   9.96%
01/07/19 7.11 7.81 7.01 167,368 7.53 0.66   9.61%
01/04/19 6.48 7.04 6.48 124,500 6.87 0.48   7.51%
01/03/19 6.67 6.93 6.17 190,364 6.39 -0.29   -4.34%
Xenon Pharmace Cm Sh (XENE) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Xenon Pharmace Cm Sh Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

XENE Stock Grade: B
Fundamental Grade: C
Quantitative Grade: A
XENE Earnings
Earnings Growth: C
Earnings Momentum: B
Earnings Surprises: D
Analyst Earnings Revisions: C
XENE Financial Information
Sales Growth: C
Operating Margin Growth: C
Cash Flow: F
Return on Equity: F

Xenon Pharmace Cm Sh Stock: Weekly View

This Week: B
Last Week: B
Two Weeks Ago: B
Get Full Report